Left Menu
Development News Edition

First, second dose should be of same Covid-19 vaccine; pregnant, lactating women must avoid vaccine now

Citing precautions and contraindications for COVID-19 vaccination ahead of massive immunisation scheduled on January 16, the Union Health Ministry has said that interchangeability of vaccine is not permitted while pregnant and lactating mothers should not receive COVID-19 vaccine at this time.

ANI | New Delhi | Updated: 14-01-2021 23:21 IST | Created: 14-01-2021 23:21 IST
First, second dose should be of same Covid-19 vaccine; pregnant, lactating women must avoid vaccine now
Representative image. Image Credit: ANI

By Priyanka Sharma Citing precautions and contraindications for COVID-19 vaccination ahead of massive immunisation scheduled on January 16, the Union Health Ministry has said that interchangeability of vaccine is not permitted while pregnant and lactating mothers should not receive COVID-19 vaccine at this time.

In a letter to the States/Union Territories, the health ministry has shared the competitive factsheet for both the vaccines (Covishield and Covaxin). They contain information on vaccine platform, physical specifications, dosage, cold storage requirements, contraindications and minor AEFIs. The health ministry has directed the States/UTs to disseminate information to program managers across all levels and through them to call chain handlers and vaccinators for ready reference.

Mentioning precautions and contraindications for COVID-19 vaccination, the letter noted: "Under the emergency use authorisation, COVID-19 vaccination is indicated only for 18 years and above. Interchangeability of COVID-19 vaccine is not permitted. The second dose should also be of the same COVID-19 vaccine which was administered as the first dose." In case of co-administration of vaccines: if required, COVID-19 vaccine and other vaccines should be separated by an interval of at least 14 days, the ministry said.

Explaining contraindication, the letter said, "A person with a history of an anaphylactic or allergic reaction to a previous dose of COVID-19 vaccine. Immediate or delayed onset anaphylaxis or allergic reaction to vaccine or injection able therapies, pharmaceutical products, food items etc." "Pregnancy and lactation: pregnant and lactating women have not been part of any COVID-19 vaccine clinical trial so far. Therefore, women who are pregnant or not sure of the pregnancy, and lactating women should not receive COVID-19 vaccine at this time," the government said.

Provisional and temporary contraindications: in these conditions, COVID-19 vaccination is to be deferred for 4 to 8 weeks after recovery. "Persons having active symptoms of SARS-CoV2 to infection. SARS-CoV2 patients who have been given anti-SARS-CoV2 monoclonal antibodies on convalescent plasma. Acutely unwell and hospitalized patients (with or without intensive care) patients due to any illness.

Special precautions: vaccine should be administered with caution in persons with a history of any bleeding or coagulation disorder, for example, clotting factor deficiency, coagulopathy or platelet disorder. Following conditions are not contraindicated for COVID-19 vaccines: a person with a past history of SARS-CoV2 infection or and or RTPCR positive illness. History of chronic diseases and comorbidities (cardiac, neurological, pulmonary, metabolic, renal, malignancies).

Immuno-deficiency, HIV, patients on immunosuppression due to any condition (response to the Covid vaccine may be less in these individuals. Other important issues to consider are that vaccine-specific contraindications may apply as the new information becomes available. India has got two Covid-19 vaccines--Covishield and Covaxin Emergency Use Authorisation after meeting going through established safety and immunogenicity through a well prescribed regulatory process.

This vaccine may cost in the range of Rs 200 to 295 in India. Earlier in the day, the health ministry said that full initial procurement amount of 1.65 crore doses of COVISHIELD and COVAXIN vaccines have been allocated to all states and Union Territories in the proportion of Health Care Workers database. (ANI)

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

China: A savior for emerging markets or a poison pill?

... ...

Future of Urban Planning: Artificial Intelligence guiding the way

Advances in emerging technologies like Artificial Intelligence and Machine Learning can help us understand our cities better and derive useful insights from real-time data collected through automated models....

Videos

Latest News

UPDATE 2-Biden administration to unveil more climate policies, urges China to toughen emissions target

U.S. President Joe Bidens administration next week will release more policies it believes are needed to tackle climate change and is urging China to toughen one of its targets on greenhouse gas emissions, his top climate advisers said on Sa...

Exit poll: Incumbent wins Portugal's presidential election

Portugals president appeared poised to win a second term in office Sunday, in an election held amid a devastating COVID-19 surge that has made the European country the worst in the world for cases and deaths.An exit poll suggested that cent...

Soccer-Serie A talking points

Talking points from the weekends Serie A matches CONTE IN HOT WATER OVER REFEREE RAGEAntonio Conte wasnt happy at the end of Inter Milans 0-0 draw at Udinese on Saturday. His side struggled to break down a team they were expected to beat, b...

EXCLUSIVE-Biden to impose South Africa travel ban to combat new COVID-19 variant -CDC

President Joe Biden will impose a ban on most non-U.S. citizens entering the country who have recently been in South Africa starting Saturday in a bid to contain the spread of a new variant of COVID-19, a senior U.S. public health official ...

Give Feedback